ClinicalTrials.Veeva

Menu

Adherence to Medical Treatments for Telemedicine Patients

University of Virginia logo

University of Virginia

Status

Terminated

Conditions

Medication Adherence
Stroke

Treatments

Device: MedRem application

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will test the feasibility of MedRem, a novel medication reminder and tracking system on wearable wrist devices, specifically with the Apple Watch 4. The study team will load the MedRem app onto two Apple Watch 4s for use during the study. As the device is placed on the wrist, it is free from the limitations of smartphones. However, one of the major challenges in developing interactive systems for wrist devices is their form factor. The touch screens available on these devices are tiny and much smaller compared to smart phones and tablet computers. MedRem enables user interactions by incorporating speech recognition and text-to-speech features along with clever interface design. The tiny display of the device is used for minimal inputs and outputs, while a user can retrieve and provide more information from/to the system through voice commands. Personalized models are built and updated over time to reduce errors in recognizing users' voice commands, and thus better user experience is provided.

Enrollment

5 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Phase 1 (Controls)

    • 18 - 75 years old
    • Good general health (self-reported), with no history of cerebral vascular accident (CVA)
    • English-speaking
    • Willingness and ability to comply with scheduled visits and study procedures

Phase 2 (Stroke Patients)

  • 18 - 75 years old
  • English-speaking
  • Willingness and ability to comply with scheduled visits and study procedures
  • Have requirements for home- based therapy regimens (i.e. physical/occupational therapy)
  • Require medications for secondary stroke prevention (e.g. antithrombotic therapy to prevent ischemic stroke, stroke risk factor management with blood pressure, diabetes, cholesterol medications).
  • Have a Modified Rankin Scale for Neurologic Disability (MDS) of 2 - 4

Exclusion criteria

  • Phase 1 (Controls)

    • Pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking subjects
    • Prohibitive cognitive impairments or language deficits
    • Does not have wireless internet connection at home

Phase 2 (Stroke Patients)

  • Pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, non-English speaking subjects
  • Have a Modified Rankin Scale for Neurologic Disability (MDS) of 0-1 or 5
  • Prohibitive cognitive impairments or language deficits
  • Significant weakness, dystonia, or spasticity that will prevent proper use and response to the Apple Watch device
  • Live in nursing home or rehabilitation facility
  • Does not have wireless internet connection at home

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Sequential Assignment

Masking

None (Open label)

5 participants in 1 patient group

MedRem application
Experimental group
Description:
MedRem smartwatch application
Treatment:
Device: MedRem application

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems